Kaletra and Breathing difficulty - from FDA reports


Summary

Breathing difficulty is found among people who take Kaletra, especially for people who are male, 50-59 old , have been taking the drug for < 1 month, also take medication Viread, and have Preventive health care. This review analyzes which people have Breathing difficulty with Kaletra. It is created by eHealthMe based on reports of 17,222 people who have side effects when taking Kaletra from FDA , and is updated regularly.

What to expect?

If you take Kaletra and have Breathing difficulty, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Kaletra and have Breathing difficulty

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 14, 2017

17,222 people reported to have side effects when taking Kaletra.
Among them, 390 people (2.26%) have Breathing difficulty


Number of reports submitted per year:

Could Kaletra cause Breathing difficulty?

Time on Kaletra when people have Breathing difficulty *:

  • < 1 month: 29.93 %
  • 1 - 6 months: 15.65 %
  • 6 - 12 months: 17.01 %
  • 1 - 2 years: 7.48 %
  • 2 - 5 years: 24.49 %
  • 5 - 10 years: 5.44 %
  • 10+ years: 0.0 %

Gender of people who have Breathing difficulty when taking Kaletra *:

  • female: 24.8 %
  • male: 75.2 %

Age of people who have Breathing difficulty when taking Kaletra *:

  • 0-1: 1.41 %
  • 2-9: 0.7 %
  • 10-19: 0.35 %
  • 20-29: 4.58 %
  • 30-39: 23.59 %
  • 40-49: 25.35 %
  • 50-59: 30.99 %
  • 60+: 13.03 %

Top conditions involved for these people *:

  • Preventive Health Care (23 people, 5.90%)
  • Acquired Immunodeficiency Syndrome (18 people, 4.62%)
  • Oral Candidiasis (16 people, 4.10%)
  • High Blood Pressure (14 people, 3.59%)
  • Gastroesophageal Reflux Disease (14 people, 3.59%)

Top co-used drugs for these people *:

  • Viread (71 people, 18.21%)
  • Norvir (60 people, 15.38%)
  • Epivir (56 people, 14.36%)
  • Truvada (52 people, 13.33%)
  • Combivir (48 people, 12.31%)

Top other side effects for these people *:

  • Fever (94 people, 24.10%)
  • Weakness (64 people, 16.41%)
  • Nausea (60 people, 15.38%)
  • Fatigue (53 people, 13.59%)
  • Diarrhea (52 people, 13.33%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Breathing difficulty when taking Kaletra?

Expand the study to include all drugs with the same ingredients

Breathing difficulty and drugs with ingredients of lopinavir; ritonavir.

Expand the study to include reports from both FDA and eHealthMe

Breathing difficulty and Kaletra from FDA and eHealthMe reports

Kaletra

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)

Breathing difficulty

Breathing difficulty has been reported by people with high blood pressure, chronic obstructive pulmonary disease, asthma, primary pulmonary hypertension, rheumatoid arthritis (latest reports from 313,725 Breathing difficulty patients).

Browse all side effects of Kaletra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Breathing difficulty

Breathing difficulty

Could your condition cause Breathing difficulty

Breathing difficulty

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Kaletra and have Breathing difficulty.

Questions to the study

More questions >

User reviews to the study

More reviews >